Vaccines

knight with sword and shield

Research sheds light on how RSV wards off potential vaccines

Respiratory syncytial virus (RSV) is the major cause of life-threatening viral pneumonia in infants worldwide, yet despite repeated efforts, scientists have been unable to develop an effective vaccine against it.

goofy toy disguise

Research team takes aim at Ebola virus ‘decoy protein’

Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system.

Vanderbilt and Human Vaccines Project launch initial studies to decode the human immune system

Researchers at Vanderbilt University Medical Center this month began recruiting volunteers to participate in a clinical trial aimed at decoding the human “immunome,” the genetic underpinnings of the immune system.

Vanderbilt mourns loss of pediatrics icon Wadlington

William B. Wadlington, M.D., a graduate of the Vanderbilt University School of Medicine class of 1952 and former member of the Board of Monroe Carell Jr. Children’s Hospital at Vanderbilt, died May 18. He was 89.

HIV cell

Potent HIV antibodies suggest new vaccine development approach

It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks.

Vanderbilt researchers identify potential antibody treatment for H7 avian flu

Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.

1 10 11 12 13 14